mynth
09/2014MajorityLBO

Eurazeo takes majority stake in Colisée

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV €100–350M

Context

The acquisition of Groupe Colisée by Eurazeo PME is a strategic move that aligns with the firm's investment strategy of supporting companies that are well-positioned to benefit from underlying societal trends. With the aging population and increasing demand for elderly care services, Groupe Colisée is well-positioned for growth and expansion. Eurazeo PME's investment in Groupe Colisée is intended to support the group's continued development and consolidation of the French retirement home market, as well as its expansion into new markets, including China. The acquisition is also expected to enable Groupe Colisée to strengthen its services and offerings, particularly in terms of dependency care, and to further enhance its reputation for quality and excellence. By partnering with Eurazeo PME, Groupe Colisée aims to capitalize on the growing demand for elderly care services and to establish itself as a leading player in the French and international markets.

The acquisition of Colisée is part of the growth strategy of Eurazeo, which already has several external growth operations under its belt, notably Desigual in 2014.

Colisée, which reported an EBITDA margin of [members only] in 2014, is valued in this transaction at an EV/EBITDA multiple of 5x–12x.

-> Deep-dive in Healthcare & Pharma market trends

Target

Colisée is the fourth largest French EHPAD operator, founded in 1976 and chaired by Christine Jeandel. The group operates numerous establishments across France, Spain, Belgium, Italy, and China. Colisée has grown significantly through an active buy-and-build strategy. Colisée is recognised as one of the leading pan-European elderly care platforms, combining a strong French domestic base with meaningful international operations across Southern Europe and Asia.

Ent. Value

€100–350M

Equity Value

[members only]

Multiples

EV / Revenue

below 1.5x

EV / EBITDA

5x–12x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2014
€100–200M
€5–25M
[members only]
2013
€100–200M
€5–25M
[members only]

Other operations with Colisée

Other operations with Colisée
DateAcquirerTargetCountrySector
09/2020EQT PARTNERSCOLISÉEFRANCENursing Homes
04/2019COLISÉEARMONEABELGIUMNursing Homes
04/2017EQT PARTNERSCOLISÉEFRANCENursing Homes

Other operations with Eurazeo

Other operations with Eurazeo
DateAcquirerTargetCountrySector
04/2016EURAZEO / MERIEUX EQUITY PARTNERSNOVACAPFRANCESpecialty Chemicals
03/2016EURAZEOGLION INSTITUTE / LES ROCHESSWITZERLANDEducation Providers
11/2015EURAZEOPLANET PAYMENTIRELANDFintech & Payments
03/2014EURAZEODESIGUALSPAINFashion & Apparel
02/2014EURAZEOVIGNAL GROUPFRANCEAuto Parts & Systems
01/2014EURAZEOASMODEE GROUPFRANCEConsumer Products
07/2013EURAZEOEVERNEXFRANCEMSP (Managed Services)
06/2013EURAZEOIES SYNERGYFRANCEBatteries & EV Tech
06/2013EURAZEOPÉTERS SURGICALFRANCEMedical Consumables
06/2011EURAZEOMONCLERITALYFashion & Leather Goods

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
01/2015CERBA HEALTHCARENOVESCIAFRANCELabs (Biology)
10/2014WATERLANDMEDIAN KLINIKENGERMANYClinics / Hospitals
06/2014PAI PARTNERSDOMUSVIFRANCENursing Homes
03/2014EQT PARTNERSI-MED RADIOLOGY NETWORKAUSTRALIARadiology
07/2012MANAGEMENT & PRIVATE INVESTORSLVL MEDICAL GERMANYGERMANYOutpatient Care
06/2012AIR LIQUIDEORKYN (EX LVL MEDICAL)FRANCEOutpatient Care
12/2010SAGA GROUPNESTOR HEALTHCARE GROUPUNITED KINGDOMOutpatient Care
06/2010PAI PARTNERSCERBA HEALTHCAREFRANCELabs (Biology)
05/2010HG CAPITALFRÖSUNDASWEDENHealthcare Facilities
03/2010BRIDGEPOINTCARE UKUNITED KINGDOMNursing Homes

REFERENCES

Valuation range: EV €100–350M

Revenue range: €100–200M

EBITDA range: €5–25M

EV/Revenue range: below 1.5x

EV/EBITDA range: 5x - 12x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Colisée by Eurazeo are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Colisée, a French company specialised in Healthcare Facilities, by Eurazeo in 2014, structured as a leveraged buyout (LBO). Ownership has since evolved, leading to a subsequent transaction with EQT Partners in April 2017 (see the dedicated deal page for details).

How was the acquisition of Colisée by Eurazeo valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €100–350M band, its EV/EBITDA multiple within the 5x - 12x range, and its EV/revenue multiple within the below 1.5x range. Exact figures are available to members.

What were Colisée’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Colisée generated annual revenue estimated in the €100–200M range and EBITDA in the €5–25M bracket (FY 2014). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.